Medical Equipment

Global Multiplex PCR Assays Market Valuation and Growth Prospects: $2.8 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the multiplex pcr assays market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Multiplex PCR Assays Market Size?

The multiplex pcr assays market has experienced substantial growth in recent years. It is projected to expand from $1.51 billion in 2024 to $1.7 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.8%. The expansion observed historically is attributable to factors such as the heightened incidence of infectious diseases, increased governmental funding and support, wider implementation in clinical diagnostics, the surge in genetic testing and personalized medicine, more extensive utilization in academic and research institutions, progress in bioinformatics and data analysis tools, and rising healthcare expenditures.

The multiplex pcr assays market is projected for swift expansion over the coming years, reaching $2.8 billion by 2029, driven by a compound annual growth rate (CAGR) of 13.3%. This anticipated growth during the forecast period is fueled by several factors, including broader application domains, an increasing need for point-of-care diagnostics, advancements in personalized medicine, higher spending on research and development, greater public health consciousness and adoption of preventive healthcare, a stronger emphasis on precision medicine, and a growing need for quick and dependable diagnostic solutions. Key developments anticipated within this timeframe encompass the incorporation of next-generation sequencing (NGS), the evolution of companion diagnostics, digital PCR technology, the implementation of automation and high-throughput systems, the emergence of point-of-care and portable devices, improved customization and multiplexing features, the application of artificial intelligence and machine learning, advanced data management practices, and cloud-based solutions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp

What Core Market Drivers Are Expanding The Multiplex PCR Assays Industry?

The multiplex PCR assay market is anticipated to experience growth driven by the rising need for diagnostic testing. Diagnostic testing encompasses procedures and examinations performed to ascertain the presence or absence of a disease or condition in a patient. This heightened demand for such testing is fueled by an increase in chronic diseases like cancer and diabetes, which necessitate early and accurate diagnosis for effective management. Additionally, the growing emphasis on preventive healthcare promotes regular testing to detect potential health issues promptly. Multiplex PCR assays are crucial in this context, enabling the simultaneous identification and analysis of multiple pathogens or genetic markers from a single sample, which significantly improves the efficiency and comprehensiveness of diagnostic testing. For instance, in July 2024, the National Health Service (NHS), a U.K.-based hospital and healthcare provider, reported that diagnostic activity had surpassed pre-pandemic levels in 2023, noting a 21% increase in tests performed in May 2024 compared to the previous year, with 2.4 million diagnostic tests carried out in May 2024. Thus, the increasing demand for diagnostic testing is poised to propel the expansion of the multiplex PCR assay market.

What Segment Insights Are Highlighted In The Multiplex PCR Assays Market Report?

The multiplex pcr assaysmarket covered in this report is segmented –

1) By Assay Type: Planar Assay, Bead Based Assay

2) By Product And Services: Consumables, Instruments, Software And Services

3) By Application: Disease Diagnosis, Research And Development, Other Applications

4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users

Subsegments:

1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays

2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

Which Notable Trends Are Transforming The Multiplex PCR Assays Market Outlook?

Major entities active in the multiplex PCR assays market are concentrating on embedding automation, specifically next-generation quantitative PCR (qPCR) systems, to enable precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems are characterized by their high-throughput, accuracy, and simultaneous detection capabilities for multiple targets, which in turn enhances diagnostic accuracy and efficiency. For example, in November 2023, Roche Diagnostics Corporation, a Switzerland-based producer of diagnostic system solutions, launched the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and concurrent detection of various targets. It features enhanced temperature uniformity, advanced software, and is compatible with over 200 LightMix Modular and 60 CE-IVD assays, thus improving diagnostic accuracy and efficiency. This system serves as a clear instance of automation integration within the Multiplex PCR Assays market, contributing to progress in clinical diagnostics and public health.

Which Firms Are Driving Innovation Within The Multiplex PCR Assays Market?

Major companies operating in the multiplex PCR assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

What Regional Trends Are Shaping Growth In The Multiplex PCR Assays Market?

North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp

Browse Through More Reports Similar to the Global Multiplex PCR Assays Market 2025, By The Business Research Company

Multiplex Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Pcr And Realtime Pcr Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795